Sign in
4

Changes in Ownership

Atara Biotherapeutics, Inc. Filed Acc 0001140361-23-028153

Director acquired 57,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Gallagher Carol Giltner · Director

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2023-05-31 Grant or award : show line 1 in the form +57,000 189,418 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-05-31 Grant or award : show line 2 in the form Non-Qualified Stock Option (Right to Buy) +79,500 79,500 D
Loading xslF345X04/form4.xml…